JP2013523740A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013523740A5 JP2013523740A5 JP2013502688A JP2013502688A JP2013523740A5 JP 2013523740 A5 JP2013523740 A5 JP 2013523740A5 JP 2013502688 A JP2013502688 A JP 2013502688A JP 2013502688 A JP2013502688 A JP 2013502688A JP 2013523740 A5 JP2013523740 A5 JP 2013523740A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- compound according
- pharmaceutical composition
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31952110P | 2010-03-31 | 2010-03-31 | |
| US61/319,521 | 2010-03-31 | ||
| PCT/US2011/030131 WO2011123372A1 (en) | 2010-03-31 | 2011-03-28 | Purine compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013523740A JP2013523740A (ja) | 2013-06-17 |
| JP2013523740A5 true JP2013523740A5 (enExample) | 2014-05-08 |
| JP5669926B2 JP5669926B2 (ja) | 2015-02-18 |
Family
ID=44041625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013502688A Expired - Fee Related JP5669926B2 (ja) | 2010-03-31 | 2011-03-28 | プリン化合物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8759360B2 (enExample) |
| EP (1) | EP2552921B1 (enExample) |
| JP (1) | JP5669926B2 (enExample) |
| KR (1) | KR20130000402A (enExample) |
| CN (1) | CN102803266B (enExample) |
| AR (1) | AR080711A1 (enExample) |
| AU (1) | AU2011232841B2 (enExample) |
| BR (1) | BR112012024586A2 (enExample) |
| CA (1) | CA2795080C (enExample) |
| EA (1) | EA020529B1 (enExample) |
| ES (1) | ES2552431T3 (enExample) |
| MX (1) | MX2012011166A (enExample) |
| TW (1) | TW201204365A (enExample) |
| WO (1) | WO2011123372A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA104010C2 (en) * | 2008-12-18 | 2013-12-25 | Эли Лилли Энд Компани | Purine compounds |
| CA2754890C (en) * | 2009-03-13 | 2018-01-16 | Piet Herdewijn | Bicyclic heterocycles |
| UA111640C2 (uk) * | 2011-11-08 | 2016-05-25 | Ф. Хоффманн-Ля Рош Аг | ПОХІДНІ [1,2,3]ТРИАЗОЛО[4,5-d]ПІРИМІДИНУ ЯК АГОНІСТИ КАНАБІНОЇДНОГО РЕЦЕПТОРА 2 |
| US9067943B2 (en) * | 2011-11-25 | 2015-06-30 | Hoffmann-La Roche Inc. | [1,2,3]triazolo[4,5-D]pyrimidine derivatives |
| JP6669743B2 (ja) * | 2014-11-07 | 2020-03-18 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | カンナビノイド受容体２のアゴニストとしてのトリアゾロ［４，５−ｄ］ピリミジン |
| WO2017181320A1 (en) | 2016-04-18 | 2017-10-26 | Eli Lilly And Company | Treatment for nonalcoholic steatohepatitis and fibrosis |
| CN109553622A (zh) * | 2017-09-27 | 2019-04-02 | 扬子江药业集团有限公司 | 一种替格瑞洛杂质的制备方法 |
| CN118946565A (zh) * | 2022-07-21 | 2024-11-12 | 长春金赛药业有限责任公司 | 取代的稠环大麻素受体化合物及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60260579A (ja) | 1984-01-13 | 1985-12-23 | Yoshitomi Pharmaceut Ind Ltd | プリン誘導体 |
| US5057517A (en) * | 1987-07-20 | 1991-10-15 | Merck & Co., Inc. | Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents |
| NZ225447A (en) | 1987-07-20 | 1991-12-23 | Merck & Co Inc | Piperazinyl derivatives of purine and purine isosteres and pharmaceutical compositions |
| TW444018B (en) * | 1992-12-17 | 2001-07-01 | Pfizer | Pyrazolopyrimidines |
| WO2003022214A2 (en) | 2001-09-06 | 2003-03-20 | Millennium Pharmaceuticals, Inc. | Piperazine and homopiperazine compounds |
| US20030139427A1 (en) | 2002-08-23 | 2003-07-24 | Osi Pharmaceuticals Inc. | Bicyclic pyrimidinyl derivatives and methods of use thereof |
| US7129239B2 (en) * | 2002-10-28 | 2006-10-31 | Pfizer Inc. | Purine compounds and uses thereof |
| US20050187389A1 (en) | 2004-01-13 | 2005-08-25 | Ambit Biosciences Corporation | Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases |
| WO2006128172A2 (en) | 2005-05-26 | 2006-11-30 | Synta Pharmaceuticals Corp. | Method for treating b cell regulated autoimmune disorders |
| WO2010019762A1 (en) * | 2008-08-13 | 2010-02-18 | Jenrin Discovery | Purine compounds as cannabinoid receptor blockers |
| UA104010C2 (en) | 2008-12-18 | 2013-12-25 | Эли Лилли Энд Компани | Purine compounds |
-
2011
- 2011-03-22 AR ARP110100930A patent/AR080711A1/es not_active Application Discontinuation
- 2011-03-24 TW TW100110223A patent/TW201204365A/zh unknown
- 2011-03-28 BR BR112012024586A patent/BR112012024586A2/pt not_active IP Right Cessation
- 2011-03-28 CN CN201180015213.6A patent/CN102803266B/zh not_active Expired - Fee Related
- 2011-03-28 ES ES11713138.3T patent/ES2552431T3/es active Active
- 2011-03-28 AU AU2011232841A patent/AU2011232841B2/en not_active Ceased
- 2011-03-28 US US13/072,843 patent/US8759360B2/en active Active
- 2011-03-28 EA EA201270728A patent/EA020529B1/ru not_active IP Right Cessation
- 2011-03-28 EP EP11713138.3A patent/EP2552921B1/en not_active Not-in-force
- 2011-03-28 WO PCT/US2011/030131 patent/WO2011123372A1/en not_active Ceased
- 2011-03-28 KR KR1020127025716A patent/KR20130000402A/ko not_active Abandoned
- 2011-03-28 MX MX2012011166A patent/MX2012011166A/es not_active Application Discontinuation
- 2011-03-28 CA CA2795080A patent/CA2795080C/en not_active Expired - Fee Related
- 2011-03-28 JP JP2013502688A patent/JP5669926B2/ja not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013523740A5 (enExample) | ||
| JP2013542247A5 (enExample) | ||
| JP2013508279A5 (enExample) | ||
| JP2013518107A5 (enExample) | ||
| JP2013522326A5 (enExample) | ||
| JP2013545785A5 (enExample) | ||
| JP2012255026A5 (enExample) | ||
| RU2013121788A (ru) | Ингибиторы репликации вич | |
| RU2017105353A (ru) | Соединения | |
| JP2012532874A5 (enExample) | ||
| JP2010523522A5 (enExample) | ||
| JP2009514870A5 (enExample) | ||
| JP2013509429A5 (enExample) | ||
| PH12018550049A1 (en) | Protein kinase inhibitor, preparation method and medical use thereof | |
| JP2017523225A5 (enExample) | ||
| JP2017531619A5 (enExample) | ||
| JP2014518266A5 (enExample) | ||
| JP2010525056A5 (enExample) | ||
| JP2015511609A5 (enExample) | ||
| JP2016534063A5 (enExample) | ||
| JP2014505107A5 (enExample) | ||
| HRP20211278T1 (hr) | Supstituirani derivati indolina kao inhibitori replikacije denga virusa | |
| JP2015522018A5 (enExample) | ||
| JP2013514980A5 (enExample) | ||
| JP2015522033A5 (enExample) |